Financial Performance - In 2024, the company's total operating revenue decreased by 34.52%, with a total profit drop of 128.59% and a net profit attributable to shareholders down by 110.56%[5]. - The net profit excluding non-recurring gains and losses fell by 212.98%, indicating significant financial distress[5]. - The company reported an operating income below 100 million RMB, leading to a risk warning for potential delisting due to the impact of order revenue recognition[5]. - The company's operating revenue for 2024 was ¥81,605,885.57, a decrease of 34.52% compared to ¥124,627,815.87 in 2023[21]. - The net profit attributable to shareholders for 2024 was -¥1,646,201.09, representing a decline of 110.56% from ¥15,583,091.37 in 2023[20]. - The net profit after deducting non-recurring gains and losses was -¥11,446,519.73 in 2024, down 212.98% from ¥10,131,265.09 in 2023[20]. - The gross profit margin was 23.47%, down 13.28% year-on-year[51]. - The company experienced a 62.96% decrease in sales volume, with only 10 units sold compared to 27 units in the previous year[57]. Cash Flow and Assets - The net cash flow from operating activities improved significantly to ¥79,992,333.68 in 2024, compared to -¥3,995,523.15 in 2023, marking a 2,102.05% increase[20]. - Total assets at the end of 2024 reached ¥792,142,257.20, an increase of 9.42% from ¥723,960,803.05 at the end of 2023[20]. - The company's total liabilities decreased by 4.02% from the previous year, with net assets attributable to shareholders at ¥634,169,234.91 at the end of 2024[20]. - Operating cash inflow for 2024 reached ¥234,377,853.96, a 66.69% increase compared to ¥140,605,733.45 in 2023[66]. - The company's cash and cash equivalents decreased by 3.55% to ¥147,893,598.90 at the end of 2024, down from ¥160,868,990.72 at the beginning of the year[71]. Research and Development - The company has obtained 47 patent certificates, including 18 invention patents and 29 utility model patents, showcasing its strong R&D capabilities[45]. - Research and development expenses rose by 11.75% to ¥16,165,876.07, attributed to increased salaries for R&D personnel[62]. - The company's R&D investment for 2024 amounted to ¥16,165,876.07, representing 19.81% of operating revenue, a significant increase from 11.61% in 2023[66]. - The total number of R&D personnel increased by 8.33% to 26 in 2024, with a notable rise in the number of employees under 30 years old, increasing from 1 to 7[66]. Market and Industry Outlook - The membrane industry in China is projected to grow at an annual rate of 10% to 12%, with total industry output expected to reach ¥500 billion to ¥600 billion by 2026[30]. - The global industrial wastewater treatment market is experiencing rapid growth due to increasing industrial wastewater discharge and heightened environmental awareness[34]. - The company is focusing on improving the recovery rate of valuable salts from fly ash wastewater, which has high economic value and meets reuse standards[64]. Governance and Compliance - The company has established a governance structure that complies with relevant laws and regulations, ensuring transparency and protecting shareholder interests[100]. - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with governance requirements[101]. - The company has implemented an internal audit system to enhance operational management and risk control[102]. - The company has a complete and independent financial management system, fulfilling its tax obligations as an independent taxpayer[105]. Shareholder and Management Information - The company held its annual shareholder meeting on May 15, 2024, with a participation rate of 50.12%[108]. - The company plans to distribute a cash dividend of RMB 3.60 per 10 shares, totaling RMB 22,962,047.76, based on a total share capital of 63,783,466 shares as of December 31, 2023[133]. - The total remuneration paid to directors, supervisors, and senior management during the reporting period amounted to 5.9932 million yuan[118]. - The company has a total of 98 employees who received compensation during the reporting period, reflecting a stable employment situation[130]. Risks and Challenges - The company faces risks from intensified market competition and will maintain investment in technology R&D to strengthen its core competitiveness[94]. - The accounts receivable risk is increasing due to a growing number of new clients, and the company will manage client credit ratings to mitigate this risk[96]. - The company is in the pilot stage of developing a zero discharge and resource utilization process for wastewater in the coal-to-olefins industry, which is expected to create significant economic benefits[64]. Future Plans and Strategies - The company plans to continue promoting the construction of its R&D projects while carefully evaluating the situation regarding expected returns[84]. - The company aims to assist industrial enterprises in achieving clean production and green transformation, benefiting both economic and environmental outcomes[38]. - The company aims to expand its international business by participating in overseas industry exhibitions and targeting markets in Southeast Asia, South Asia, Africa, and Europe[93].

证券代码：300899 证券简称：上海凯鑫 公告编号：2025-009 上海凯鑫分离技术股份有限公司 关于公司股票可能被实施退市风险警示的 第三次提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特此公告。 上海凯鑫分离技术股份有限公司董事会 特别提示： 上海凯鑫分离技术股份有限公司（以下简称"公司"）预计 2024 年度归属于 上市公司股东的扣除非经常性损益的净利润为负值且扣除后营业收入低于 1 亿 元，根据《深圳证券交易所创业板股票上市规则》第 10.3.1 条规定，在公司 2024 年年度报告披露后，公司股票交易可能被实施退市风险警示（股票简称前冠以 "*ST"字样），敬请广大投资者注意投资风险。 一、本次可能被实施退市风险警示的主要原因 根据《深圳证券交易所创业板股票上市规则》第 10.3.1 条第（一）项的规定， 上市公司出现"最近一个会计年度经审计的利润总额、净利润、扣除非经常性损 益后的净利润三者孰低为负值，且扣除后的营业收入低于 1 亿元"的情形，公司 股票交易将被实施退市风险警示。 根据经会计师事务所审计的初稿，预计公司 2024 ...

上海凯鑫（300899）4月22日发布提示公告称，经会计师事务所审计的初稿显示，上海凯鑫预计2024年 度利润总额为-444.53万元，净利润为-164.62万元，扣除非经常性损益的净利润为-1,144.65万元，扣除后 的营业收入为8,160.59万元。根据《深圳证券交易所创业板股票上市规则》第10.3.1条规定，公司股票交 易可能在2024年年度报告披露后被实施退市风险警示，股票简称前将冠以"*ST"字样，投资者需注意相 关风险。 截至本公告日，公司2024年度财务报告审计工作仍在进行中，最终财务数据请以公司正式披露的经审计 后的2024年年度报告为准。若公司2024年度经审计的财务数据触及《深圳证券交易所创业板股票上市规 则》第10.3.1条的相关规定，公司将在披露《2024年年度报告》的同时，披露公司股票交易将被实施退 市风险警示的公告。公司股票将于公告后停牌一天，自复牌之日起，深圳证券交易所将对公司股票交易 实施退市风险警示。 公司同时发布的一季报预告显示，公司今年一季度实现营业收入7100万元-9100万元，同比增 127.13%-191.11%，实现净利润1,700万元–2,150万元，同比增长 ...

证券代码：300899 证券简称：上海凯鑫 公告编号：2025-008 上海凯鑫分离技术股份有限公司 关于公司股票可能被实施退市风险警示的 第二次提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 为充分提示以上风险，根据《深圳证券交易所创业板股票上市规则》10.3.3 条规定，公司将在披露 2024 年年度报告前至少再披露一次风险提示公告。 二、风险提示 截至本公告日，公司 2024 年度财务报告审计工作仍在进行中，最终财务数 据请以公司正式披露的经审计后的 2024 年年度报告为准。 若公司 2024 年度经审计的财务数据触及《深圳证券交易所创业板股票上市 规则》第 10.3.1 条的相关规定，公司将在披露《2024 年年度报告》的同时，披 露公司股票交易将被实施退市风险警示的公告。公司股票将于公告后停牌一天， 自复牌之日起，深圳证券交易所将对公司股票交易实施退市风险警示。 特此公告。 上海凯鑫分离技术股份有限公司董事会 上海凯鑫分离技术股份有限公司（以下简称"公司"）预计 2024 年度归属 于上市公司股东的扣除非经常性损益的净利润为 ...

Core Viewpoint - Shanghai Kaixin (300899.SZ) faces significant financial challenges, including a sharp decline in annual revenue and net profit, leading to potential delisting risks due to non-compliance with disclosure regulations [1][2][3] Financial Performance - In 2024, Shanghai Kaixin reported operating revenue of 81.61 million yuan, a year-on-year decrease of 34.52%, and a net loss of 1.65 million yuan, a decline of 110.56% [2] - The company experienced a dramatic drop in Q4 2023, with revenue of 3.31 million yuan and a net loss of 8.77 million yuan [4] - Conversely, the first quarter of 2025 showed a significant increase in performance, with projected revenue between 71 million and 91 million yuan, representing a year-on-year growth of 127.13% to 191.11% [4] Revenue Recognition Issues - The discrepancies in revenue recognition between internal and external audits have led to significant adjustments in reported figures, raising questions about the company's financial management [3][5] - The company attributed the lack of timely disclosure of risks to differences in revenue recognition timing with auditors, which were only resolved later [3] Customer Concentration and Accounts Receivable - A high concentration of sales among a few customers poses risks, with the top five customers accounting for 71.67% of total sales [5][6] - As of 2023, accounts receivable stood at 115 million yuan, with a bad debt provision of 17.31 million yuan, indicating potential liquidity issues [5][6] Industry Context - The company claims to benefit from a recovery in the industry, with new orders increasing by over 20% compared to 2023, and cash received from sales rising by 69.94% [6] - The sustainability of this recovery remains uncertain, as the company has faced ongoing financial difficulties since its listing in 2020 [5][6]

重要公告： 华鲁恒升：拟2亿元—3亿元回购股份用于注销 亚振家居：控股股东筹划控制权变更事项股票18日起停牌 中国联通：一季度净利润同比增长6.5% 同飞股份：一季度净利润同比增长1104.89% 长盈精密：2024年净利润同比增长800.24% 拟10派1.3元 沪市重要公告： 华鲁恒升：拟2亿元—3亿元回购股份用于注销 亚振家居（603389）公告，因公司控股股东上海亚振投资有限公司正在筹划重大事项，该事项可能导致 公司控制权发生变更，经公司申请，公司股票将于2025年4月18日（星期五）开市起停牌，停牌时间不 超过2天。 圣泉集团：一季度净利润同比增长50.46% 圣泉集团（605589）公告，第一季度实现营业收入24.59亿元，同比增长15.14%；净利润2.07亿元，同 比增长50.46%；基本每股收益0.25元。 中国联通：一季度净利润同比增长6.5% 中国联通（600050）公告，公司2025年第一季度实现营业收入1033.5亿元，同比增长3.9%；归属于母公 司净利润26.1亿元，同比增长6.5%；基本每股收益0.083元。 华鲁恒升（600426）公告，公司拟2亿元—3亿元回购股份用于注销并 ...

Group 1 - Sanan Optoelectronics received a loan commitment letter from China Industrial Bank for a repurchase loan of 1 billion yuan, valid for three years, to support stock buybacks [2] - Changying Precision reported a 23.40% increase in revenue to 16.934 billion yuan and an 800.24% increase in net profit to 772 million yuan for 2024, driven by humanoid robot projects [2] - Zhuhai Group's Q1 net profit increased by 74.07% to 277 million yuan, attributed to gains from precious metals [2] Group 2 - Qianyuan Power expects a Q1 net profit increase of 330%-365%, driven by a 62.70% increase in water inflow and a 59.40% rise in power generation [3] - Guofang Group's stock has experienced significant volatility, with a current P/E ratio of 110.1, indicating potential irrational speculation [3] - Fangyuan Co. decided to terminate a 3 billion yuan lithium carbonate production project due to market conditions and strategic changes, having already invested 97 million yuan [4] Group 3 - Baosteel plans to acquire a 49% stake in Maanshan Steel for a total consideration of 9 billion yuan, consisting of 5.139 billion yuan for equity purchase and 3.861 billion yuan for capital increase [5]

于此同时，上海凯鑫分离技术股份有限公司与南京林业大学于2022年6月6日就"生物质材料的高值化利 用"项目签订技术开发合同。为完善公司科技创新体系建设，构建公司人才基地，培养造就高水平的科 技创新人才和高层次管理人才，保持公司在国内外的技术领先地位和持续快速发展能力，公司于2022年 被批准建企业专家工作站，专家工作站现已启动"生物质材料的高值化利用"项目的研发及专家工作站的 建设任务；公司与南京林业大学等机构的合作研发，有效整合研发资源，同时较好地提升了公司在工业 分离行业领域的技术先进性。 技术应用场景拓展，赋能行业绿色转型 在2023年意大利米兰ITMA国际纺织机械展览会上，上海凯鑫推出印染废水处理技术E-Cast System，吸 引了全球客户关注。该系统通过"末端处理+过程减废"的定制化方案，帮助印染企业降低资源消耗及运 行成本。此外，公司技术已延伸至生物医药、石油化工、新能源等高耗水行业。例如，在生物制药领 域，膜分离技术成功用于各种药品的分离提纯及废水中各种有价物质的回收利用。 在全球环保政策趋严及工业绿色转型加速的背景下，上海凯鑫（300899）分离技术股份有限公司(股票 代码：300899. ...

上海凯鑫(300899.SZ)公告称，预计2024年度归属于上市公司股东的扣除非经常性损益的 净利润为负值 且扣除后 营业收入低于1亿元，根据相关规定，公司股票交易可能在2024年年度报告披露后被实施 退市 风险警示。具体数据以公司正式披露的经审计后的2024年年度报告为准。 ...